O4‐04‐05: Aducanumab (BIIB037), an anti‐amyloid beta monoclonal antibody, in patients with prodromal or mild Alzheimer's disease: Interim results of a randomized, double‐blind, placebo‐controlled, phase 1b study. (1st July 2015) - Sevigny, Jeff; Chiao, Ping; Williams, Leslie; Chen, Tianle; Ling, Yan; O'Gorman, John; Hock, Christoph; Nitsch, Roger M.; Sandrock, Alfred